Hu Zhou

14.1k total citations · 4 hit papers
212 papers, 7.0k citations indexed

About

Hu Zhou is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, Hu Zhou has authored 212 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Molecular Biology, 41 papers in Spectroscopy and 28 papers in Oncology. Recurrent topics in Hu Zhou's work include Advanced Proteomics Techniques and Applications (36 papers), Mass Spectrometry Techniques and Applications (27 papers) and Metabolomics and Mass Spectrometry Studies (19 papers). Hu Zhou is often cited by papers focused on Advanced Proteomics Techniques and Applications (36 papers), Mass Spectrometry Techniques and Applications (27 papers) and Metabolomics and Mass Spectrometry Studies (19 papers). Hu Zhou collaborates with scholars based in China, United States and Canada. Hu Zhou's co-authors include Daniel Figeys, Rong Zeng, Hualiang Jiang, Cheng Luo, Desheng Xiao, Weiwei Lai, Yongguang Tao, Ya Cao, Yating Liu and Chao Mao and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Hu Zhou

199 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5

2014 555 citations Hu Zhou, Hualiang Jiang et al. Nucleic Acids Research profile →
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA

2019 429 citations Min Wang, Chao Mao et al. Cell Death and Differentiation profile →
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53

2018 402 citations Chao Mao, Xiang Wang et al. Cancer Research profile →
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1

2023 109 citations Jing Gao, Hu Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hu Zhou China	42	5.1k	1.8k	946	921	736	212	7.0k
James A. Mobley United States	40	3.5k 0.7×	1.1k 0.6×	445 0.5×	726 0.8×	352 0.5×	125	5.6k
Hong Cai China	42	3.3k 0.6×	603 0.3×	611 0.6×	322 0.3×	928 1.3×	184	5.8k
René P. Zahedi Germany	48	5.7k 1.1×	525 0.3×	391 0.4×	1.7k 1.8×	655 0.9×	170	8.1k
Ching‐Shih Chen United States	44	4.7k 0.9×	682 0.4×	301 0.3×	534 0.6×	1.0k 1.4×	144	6.8k
Brian L. Hood United States	38	2.7k 0.5×	576 0.3×	306 0.3×	962 1.0×	577 0.8×	105	4.4k
Minjia Tan China	37	6.4k 1.3×	1.2k 0.7×	295 0.3×	364 0.4×	1.4k 1.9×	149	8.5k
Jayoung Kim United States	43	3.4k 0.7×	1.8k 1.0×	898 0.9×	163 0.2×	841 1.1×	175	6.0k
Gÿorgý Kéri Hungary	41	3.5k 0.7×	535 0.3×	482 0.5×	458 0.5×	1.7k 2.3×	162	6.1k
Jakob Troppmair Austria	50	4.4k 0.9×	705 0.4×	327 0.3×	458 0.5×	1.0k 1.4×	157	7.9k
Hui Zhang United States	47	6.4k 1.3×	566 0.3×	478 0.5×	2.9k 3.2×	775 1.1×	205	8.4k

Countries citing papers authored by Hu Zhou

Since Specialization

Citations

This map shows the geographic impact of Hu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Zhou more than expected).

Fields of papers citing papers by Hu Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Zhou. The network helps show where Hu Zhou may publish in the future.

Co-authorship network of co-authors of Hu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Zhou. A scholar is included among the top collaborators of Hu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Zhou. Hu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ran, Haoran Qian, Xinyu Xie, et al.. (2025). Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression. Cancer Research. 85(7). 1253–1269. 2 indexed citations

Wang, Xian, Shengxiang Ren, Fang Liu, et al.. (2025). An antidepressant mechanism underlying the allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneurons. Science Advances. 11(10). eadq0444–eadq0444. 3 indexed citations

Li, Yali, et al.. (2024). A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO. RSC Chemical Biology. 5(4). 335–343. 24 indexed citations

Wang, Yuqiu, Bo Liang, Jing Zhang, et al.. (2024). A “One-Step” Strategy for the Global Characterization of Core-Fucosylated Glycoproteome. SHILAP Revista de lepidopterología. 4(5). 2005–2018. 6 indexed citations

Han, Ying, Huairui Yuan, Qiuli Liu, et al.. (2024). Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction. Oncogene. 44(1). 8–18. 2 indexed citations

Zhou, Hu, et al.. (2023). Isolation, structural characterization and quantification of impurities in bupivacaine. Journal of Pharmaceutical and Biomedical Analysis. 225. 115236–115236.

Chen, Chen, Xi Chen, Yuqiu Wang, et al.. (2023). A novel capsid-XL32-derived adeno-associated virus serotype prompts retinal tropism and ameliorates choroidal neovascularization. Biomaterials. 304. 122403–122403. 1 indexed citations

Wang, Lin, Hu Zhou, Jing Gao, et al.. (2023). Lnc956 -TRIM28-HSP90B1 complex on replication forks promotes CMG helicase retention to ensure stem cell genomic stability and embryogenesis. Science Advances. 9(4). eadf6277–eadf6277. 3 indexed citations

Yan, Kexiang, Qing‐Ren Meng, Ling Han, et al.. (2022). iTRAQ‐based quantitative proteomics reveals biomarkers/pathways in psoriasis that can predict the efficacy of methotrexate. Journal of the European Academy of Dermatology and Venereology. 36(10). 1784–1795. 10 indexed citations

10.

Yang, Nanfei, Qiang Tian, Qiuping Wang, et al.. (2022). Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions. Cell Death and Differentiation. 30(3). 766–778. 12 indexed citations

11.

Xu, Peiyu, Sijie Huang, Shimeng Guo, et al.. (2022). Structural identification of lysophosphatidylcholines as activating ligands for orphan receptor GPR119. Nature Structural & Molecular Biology. 29(9). 863–870. 41 indexed citations

12.

Yang, Jun, Yuan Liu, Yu Zhang, et al.. (2021). PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation. Cell Death and Disease. 12(7). 707–707. 9 indexed citations

13.

Wang, Maoxue, et al.. (2020). Long Noncoding RNA EBLN3P Promotes the Progression of Liver Cancer via Alteration of microRNA-144-3p/DOCK4 Signal. SHILAP Revista de lepidopterología. 3 indexed citations

14.

Li, Long, Ran Chen, Yuxue Zhang, et al.. (2019). SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells. Cancer Research. 79(17). 4387–4398. 24 indexed citations

15.

Wang, Xuan, Hui Sun, Jiaxiang Liu, et al.. (2019). Palladium-Promoted DNA-Compatible Heck Reaction. Organic Letters. 21(3). 719–723. 54 indexed citations

16.

Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 26(11). 2329–2343. 429 indexed citations breakdown →

17.

Mao, Chao, Xiang Wang, Yating Liu, et al.. (2018). A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. Cancer Research. 78(13). 3484–3496. 402 indexed citations breakdown →

18.

Chang, Lufen, Hu Zhou, Jing Gao, et al.. (2018). ITCH nuclear translocation and H1.2 polyubiquitination negatively regulate the DNA damage response. Nucleic Acids Research. 47(2). 824–842. 18 indexed citations

19.

Wang, Xuan, Hui Sun, Jiaxiang Liu, et al.. (2018). Ruthenium-Promoted C–H Activation Reactions between DNA-Conjugated Acrylamide and Aromatic Acids. Organic Letters. 20(16). 4764–4768. 68 indexed citations

20.

Yi, Jun-Mei, Xia‐Juan Huan, Shanshan Song, et al.. (2016). Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44. Molecular Cancer Therapeutics. 15(7). 1495–1503. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact